HR Execs on the Move

Hillcrest Educational Centers

www.hillcrestec.org

 
Hillcrest Educational Foundation is a private not-for-profit agency that provides a range of individualized and comprehensive clinical, psychological and special education services for children, adolescents and families in Berkshire County, MA and the Northeast. The students served by Hillcrest in nonresidential and residential programs have complex psychiatric, behavioral and/or developmental disorders, including Autism Spectrum Disorders, and a variety of high-risk behaviors. The programs and services provided by the Hillcrest Educational Foundation are state licensed and certified, and Hillcrest Educational Centers, including Hillcrest Community Support Services, is accredited in behavioral health care by the Joint Commission.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Michele Morin
 Vice President of Human Resources and Workforce Development Profile

Similar Companies

American Behavioral Benefits Managers Inc

American Behavioral Benefits Managers Inc is a Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HFS Consultants

HFS Consultants is a Oakland, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LifeGift

LifeGift offers hope to the thousands of people in Texas and beyond who need lifesaving organ transplants, and to countless others who need lifesaving tissue transplants. As the designated organ procurement organization (OPO) for North, Southeast and West Texas, we partner with more than 200 hospitals across 109 counties. Established in 1987 as Gulf Coast Independent Organ Procurement Organization, LifeGift is approved by the Centers for Medicare and Medicaid Services (CMS) and accredited by the Association of Organ Procurement Organizations (AOPO) and the American Association of Tissue Banks (AATB).

Center For Growth and Healing

Center For Growth & Healing is a Kenmore, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.